NFE2L2 and neuroblastoma: Interestingly, therapeutic Nrf2 activation with 5A-T compounds was independent of GSK-3β inhibition in SH-SY5Y human neuroblastoma cells treated with the mitochondrial toxins oligomycin/rotenone [344].